Amarantus

1 stories · following the connections

Business

Amarantus Subsidiary MANF Therapeutics Receives Notice of Allowance from U.S. Patent & Trademark Office Covering MANF Treatment of Diabetes

By Nasdaq OMXDec 11, 2017, 1:02 PM UTC